Gilead Sciences, Inc. (Nasdaq: GILD) today announced the upcoming presentation of HIV research findings at the International ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, will ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced 48-week findings from the DOLCE study, sponsored by Fundación ...
Gilead (GILD) announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV Infection, ...
Key data to be presented at HIV Glasgow 2024 by ViiV Healthcare and its study partners will include: Analysis of cabotegravir + rilpivirine long-acting (CAB+RPV LA) in the real-world and across ...
James Bushe had previously wanted to remain anonymous, using the pseudonym "Pilot Anthony" on Twitter to write about his ...
Aditxt, Inc. ("Aditxt" or the "Company"), a social innovation platform dedicated to accelerating promising health innovations, today shared an important milestone for its target acquisition, Appili ...
Peripartum HIV transmission can be reduced to under 5 ... Division of Developmental Medicine, University of Glasgow Medical Faculty, Glasgow, UK. Disclosure: The authors have no relevant ...
CHANCELLOR Rachel Reeves has announced money has been set aside to compensate those impacted by the infected blood scandal and the victims of ...
Q3 2024 Earnings Conference Call November 6, 2024 4:30 PM ETCompany ParticipantsDaniel O'Day - Chairman, Chief ...